I agree that this site is using cookies. You can find further informations here.
X
Tuttle, Jay
55  results:
Search for persons X
?
1

Changes in health-related quality of life and associations ..:

Dubinsky, Marla C ; Jairath, Vipul ; Feagan, Brian G...
BMJ Open Gastroenterology.  10 (2023)  1 - p. e001115 , 2023
Link: https://doi.org/10.1136/..
 
?
2

Mirikizumab regulates genes involved in ulcerative colitis ..:

Steere, Boyd ; Schmitz, Jochen ; Powell, Nick...
Clinical and Translational Gastroenterology.  , 2023
Link: https://doi.org/10.14309..
 
?
3

Efficacy and Safety of Continued Treatment With Mirikizumab..:

Sandborn, William J. ; Ferrante, Marc ; Bhandari, Bal R....
Clinical Gastroenterology and Hepatology.  20 (2022)  1 - p. 105-115.e14 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 ..:

Sands, Bruce E. ; Peyrin-Biroulet, Laurent ; Kierkus, Jaroslaw...
Gastroenterology.  162 (2022)  2 - p. 495-508 , 2022
Link: https://doi.org/10.1053/..
 
?
5

Innovative clinical trial design and delivery: a phase 3 CO..:

Knorr, Jack ; Tuttle, Jay L. ; Sabo, Janelle A....
Trials.  22 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
6

132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINT..:

Sands, Bruce E. ; Sandborn, William J. ; Peyrin-Biroulet, Laurent...
Gastroenterology.  160 (2021)  6 - p. S-37 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Fr543 MIRIKIZUMAB INDUCES REDUCTION OF IL-23 RELATED CYTOKI..:

Schmitz, Jochen ; Higgs, Richard ; Ho, Stephen...
Gastroenterology.  160 (2021)  6 - p. S-355-S-356 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Tu1849 HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A PHASE ..:

Pai, Rish ; Canavan, James ; Tuttle, Jay...
Gastroenterology.  158 (2020)  6 - p. S-1187 , 2020
Link: https://doi.org/10.1016/..
 
?
9

P067 IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUAL..:

Lichtenstein, Gary ; Feagan, Brian ; Tuttle, Jay...
Gastroenterology.  158 (2020)  3 - p. S16-S17 , 2020
Link: https://doi.org/10.1053/..
 
?
10

Tu1854 MIRIKIZUMAB REGULATES GENES INVOLVED IN ANTI-TNF RES..:

Steere, Boyd ; Schmitz, Jochen ; Powell, Nicholas...
Gastroenterology.  158 (2020)  6 - p. S-1189 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 ..:

Sandborn, William J. ; Ferrante, Marc ; Bhandari, Bal R....
Gastroenterology.  158 (2020)  3 - p. 537-549.e10 , 2020
Link: https://doi.org/10.1053/..
 
?
12

P067 IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUAL..:

Lichtenstein, Gary ; Feagan, Brian ; Tuttle, Jay...
Inflammatory Bowel Diseases.  26 (2020)  Supplement_1 - p. S10-S10 , 2020
Link: https://doi.org/10.1093/..
 
?
13

Tu1853 SUSTAINED REDUCTION OF IL-23 RELATED CYTOKINES IL-17..:

D'Haens, Geert R. ; Sands, Bruce E. ; Kobayashi, Taku...
Gastroenterology.  158 (2020)  6 - p. S-1188 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Sa1125 GENE EXPRESSION (GE) VALUES IN A PHASE 2 TRIAL OF MI..:

Steere, Boyd ; Gottlieb, Klaus ; Schmitz, Jochen...
Gastroenterology.  158 (2020)  6 - p. S-284-S-285 , 2020
Link: https://doi.org/10.1016/..
 
?
15

15328 Efficacy and safety of mirikizumab in patients with m..:

Bissonnette, Robert ; Maari, Catherine ; Menter, M. Alan...
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB147 , 2020
Link: https://doi.org/10.1016/..
 
1-15